Created at	Source	Raw Value	Validated value
Dec. 3, 2021, 11:30 p.m.	usa	Safety of Clazakizumab for the Treatment of Patients With COVID-19 Disease	Safety of Clazakizumab for the Treatment of Patients With COVID-19 Disease
Oct. 26, 2020, 11:31 p.m.	usa	Evaluate the safety of clazakizumab for the treatment of patients with COVID-19 disease and signs of pulmonary involvement	Evaluate the safety of clazakizumab for the treatment of patients with COVID-19 disease and signs of pulmonary involvement